OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth
Emma Scott, Kirsty Hodgson, Beatriz de la Calle, et al.
Oncogene (2023) Vol. 42, Iss. 12, pp. 926-937
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Glycosylation: mechanisms, biological functions and clinical implications
Mengyuan He, Xiangxiang Zhou, Xin Wang
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 33

ST6GAL1‐mediated aberrant sialylation promotes prostate cancer progression
Emma Scott, Emily Archer Goode, Rebecca Garnham, et al.
The Journal of Pathology (2023) Vol. 261, Iss. 1, pp. 71-84
Open Access | Times Cited: 23

Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone
Kirsty Hodgson, Margarita Orozco‐Moreno, Emily Archer Goode, et al.
EBioMedicine (2024) Vol. 104, pp. 105163-105163
Open Access | Times Cited: 13

Metabolic adaptations in prostate cancer
Mikel Pujana-Vaquerizo, Laura Bozal-Basterra, Arkaitz Carracedo
British Journal of Cancer (2024) Vol. 131, Iss. 8, pp. 1250-1262
Open Access | Times Cited: 12

ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer
Rebecca Garnham, Daniel Geh, Ryan Nelson, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 8

Altered glycosylation in cancer: molecular functions and therapeutic potential
Xuemeng Xu, Qiu Peng, Xianjie Jiang, et al.
Cancer Communications (2024) Vol. 44, Iss. 11, pp. 1316-1336
Open Access | Times Cited: 7

Mucin Glycans: A Target for Cancer Therapy
Lingbo Sun, Yuhan Zhang, Wenyan Li, et al.
Molecules (2023) Vol. 28, Iss. 20, pp. 7033-7033
Open Access | Times Cited: 14

Kushenol O Regulates GALNT7/NF-κB axis-Mediated M2 Macrophage Polarization and Efferocytosis in Papillary Thyroid Carcinoma
Yutong Li, Jianhang Miao, Chizhuai Liu, et al.
Phytomedicine (2025) Vol. 138, pp. 156373-156373
Closed Access

Targeting aberrant sialylation and fucosylation in prostate cancer cells using potent metabolic inhibitors
Margarita Orozco‐Moreno, Eline A. Visser, Kirsty Hodgson, et al.
Glycobiology (2023) Vol. 33, Iss. 12, pp. 1155-1171
Open Access | Times Cited: 11

Glycosylation in cancer as a source of biomarkers
Sara Khorami-Sarvestani, Samir Hanash, Johannes F. Fahrmann, et al.
Expert Review of Proteomics (2024) Vol. 21, Iss. 9-10, pp. 345-365
Closed Access | Times Cited: 4

The glycosylation landscape of prostate cancer tissues and biofluids
Jordan P. Hartig, Lyndsay E.A. Young, Grace Grimsley, et al.
Advances in cancer research (2024), pp. 1-30
Closed Access | Times Cited: 3

Sugar symphony: glycosylation in cancer metabolism and stemness
Venkatesh Varadharaj, W. E. Petersen, Surinder K. Batra, et al.
Trends in Cell Biology (2024)
Closed Access | Times Cited: 2

The role of GALNT7 as a potential diagnostic marker in prostate cancer
Maria Chiara Masone
Nature Reviews Urology (2023) Vol. 20, Iss. 4, pp. 198-198
Closed Access | Times Cited: 4

Comprehensive pan-cancer analysis reveals the versatile role of GALNT7 in epigenetic alterations and immune modulation in cancer
Yan Liu, Yue Sun, Meixia Xiao, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e31515-e31515
Open Access | Times Cited: 1

The role of protein post-translational modifications in prostate cancer
Yinghui Hao, Chenqiong Gu, Wenfeng Luo, et al.
PeerJ (2024) Vol. 12, pp. e17768-e17768
Open Access | Times Cited: 1

Sialylation Inhibition Can Partially Revert Acquired Resistance to Enzalutamide in Prostate Cancer Cells
Emily Archer Goode, Margarita Orozco‐Moreno, Kirsty Hodgson, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 2953-2953
Open Access | Times Cited: 1

Overexpression of sialyl lewisa carrying mucin-type glycoprotein in prostate cancer cell line contributes to aggressiveness and metastasis
Justen Manasa, Ashwini S. Sanji, Maruti J. Gurav, et al.
International Journal of Biological Macromolecules (2024) Vol. 281, pp. 136519-136519
Closed Access | Times Cited: 1

Dysbindin Domain-Containing 1 in Prostate Cancer: New Insights into Bioinformatic Validation of Molecular and Immunological Features
Van Thi Ngoc Tram, Hoang Dang Khoa Ta, Gangga Anuraga, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 11930-11930
Open Access | Times Cited: 3

GALNT12 promotes fibrosarcoma growth by accelerating YAP1 nuclear localization
Site Yu, Wenjie Feng, Jizhang Zeng, et al.
Oncology Letters (2023) Vol. 26, Iss. 6
Open Access | Times Cited: 3

Bump-and-hole engineering of human polypeptide N-acetylgalactosamine transferases to dissect their protein substrates and glycosylation sites in cells
Beatriz de la Calle, Edgar González-Rodríguez, Keira E. Mahoney, et al.
STAR Protocols (2023) Vol. 4, Iss. 1, pp. 101974-101974
Open Access | Times Cited: 2

12th Tuscany Retreat on Cancer Research and Apoptosis: Genetic profiling, resistance mechanisms and novel treatment concepts in cancer and neurodegeneration
Cristiano Ramos, Debora Bonasera, Julia Saggau, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2024) Vol. 1871, Iss. 3, pp. 119677-119677
Open Access

C1GALT1-mediated O-glycan T antigen increase enhances the migration and invasion ability of gastric cancer cells
Xiaojuan Bao, Hanjie Yu, Zhuo Chen, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 734, pp. 150641-150641
Closed Access

Rational Design of Dual-Domain Binding Inhibitors for N-Acetylgalactosamine Transferase 2 with Improved Selectivity over the T1 and T3 Isoforms
Ismael Compañón, Collin J. Ballard, Erandi Lira‐Navarrete, et al.
JACS Au (2024) Vol. 4, Iss. 9, pp. 3649-3656
Open Access

Page 1 - Next Page

Scroll to top